trans-3-Hydroxypyrrolidine-2-carboxylic acid
![]() |
- $497.1 - $772
- Product name: trans-3-Hydroxypyrrolidine-2-carboxylic acid
- CAS: 4298-06-0
- MF: C5H9NO3
- MW: 131.13
- EINECS:
- MDL Number:
- Synonyms:trans-3-Hydroxypyrrolidine-2-carboxylic acid;D-Proline, 3-hydroxy-, (3R)-rel-;rel-(3R)-3-Hydroxy-D-proline
4 prices
Selected condition:
Brand
- Alichem
- American Custom Chemicals Corporation
- Chemenu
- Crysdot
Package
- 5MG
- 1g
- ManufacturerAlichem
- Product number4298060
- Product descriptiontrans-3-Hydroxypyrrolidine-2-carboxylicacid
- Packaging1g
- Price$659.4
- Updated2021-12-16
- Buy
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberAAA0011185
- Product descriptionTRANS-3-HYDROXYPYRROLIDINE-2-CARBOXYLIC ACID 95.00%
- Packaging5MG
- Price$497.1
- Updated2021-12-16
- Buy
- ManufacturerChemenu
- Product numberCM197148
- Product description(2S,3S)-3-hydroxypyrrolidine-2-carboxylicacid 95%
- Packaging1g
- Price$729
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD21007239
- Product descriptiontrans-3-Hydroxypyrrolidine-2-carboxylicacid 95+%
- Packaging1g
- Price$772
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
Alichem | 4298060 | trans-3-Hydroxypyrrolidine-2-carboxylicacid | 1g | $659.4 | 2021-12-16 | Buy |
American Custom Chemicals Corporation | AAA0011185 | TRANS-3-HYDROXYPYRROLIDINE-2-CARBOXYLIC ACID 95.00% | 5MG | $497.1 | 2021-12-16 | Buy |
Chemenu | CM197148 | (2S,3S)-3-hydroxypyrrolidine-2-carboxylicacid 95% | 1g | $729 | 2021-12-16 | Buy |
Crysdot | CD21007239 | trans-3-Hydroxypyrrolidine-2-carboxylicacid 95+% | 1g | $772 | 2021-12-16 | Buy |
Properties
Boiling point :355.2±42.0 °C(Predicted)
Density :1.395±0.06 g/cm3(Predicted)
storage temp. :2-8°C
pka :2.03±0.40(Predicted)
Density :1.395±0.06 g/cm3(Predicted)
storage temp. :2-8°C
pka :2.03±0.40(Predicted)
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|